144 related articles for article (PubMed ID: 10204584)
1. A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets.
Heddle NM; Klama L; Meyer R; Walker I; Boshkov L; Roberts R; Chambers S; Podlosky L; O'Hoski P; Levine M
Transfusion; 1999 Mar; 39(3):231-8. PubMed ID: 10204584
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets.
Heddle NM; Blajchman MA; Meyer RM; Lipton JH; Walker IR; Sher GD; Constantini LA; Patterson B; Roberts RS; Thorpe KE; Levine MN
Transfusion; 2002 May; 42(5):556-66. PubMed ID: 12084163
[TBL] [Abstract][Full Text] [Related]
3. Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction.
Couban S; Carruthers J; Andreou P; Klama LN; Barr R; Kelton JG; Heddle NM
Transfusion; 2002 Jun; 42(6):753-8. PubMed ID: 12147029
[TBL] [Abstract][Full Text] [Related]
4. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations.
Klüter H; Bubel S; Kirchner H; Wilhelm D
Transfusion; 1999; 39(11-12):1179-84. PubMed ID: 10604243
[TBL] [Abstract][Full Text] [Related]
5. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
6. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage.
Federowicz I; Barrett BB; Andersen JW; Urashima M; Popovsky MA; Anderson KC
Transfusion; 1996 Jan; 36(1):21-8. PubMed ID: 8607149
[TBL] [Abstract][Full Text] [Related]
7. The role of the plasma from platelet concentrates in transfusion reactions.
Heddle NM; Klama L; Singer J; Richards C; Fedak P; Walker I; Kelton JG
N Engl J Med; 1994 Sep; 331(10):625-8. PubMed ID: 8052271
[TBL] [Abstract][Full Text] [Related]
8. Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method.
Muylle L; Wouters E; Peetermans ME
Transfusion; 1996 Oct; 36(10):886-90. PubMed ID: 8863775
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
Trial to Reduce Alloimmunization to Platelets Study Group
N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
[TBL] [Abstract][Full Text] [Related]
10. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study.
de Wildt-Eggen J; Nauta S; Schrijver JG; van Marwijk Kooy M; Bins M; van Prooijen HC
Transfusion; 2000 Apr; 40(4):398-403. PubMed ID: 10773049
[TBL] [Abstract][Full Text] [Related]
11. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions.
Blumberg N; Gettings KF; Turner C; Heal JM; Phipps RP
Transfusion; 2006 Oct; 46(10):1813-21. PubMed ID: 17002639
[TBL] [Abstract][Full Text] [Related]
12. Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat.
Oksanen K; Ebeling F; Kekomäki R; Elonen E; Sahlstedt L; Volin L; Myllylä G
Vox Sang; 1994; 67(4):356-61. PubMed ID: 7701806
[TBL] [Abstract][Full Text] [Related]
13. Reactions to platelet transfusion: the effect of the storage time of the concentrate.
Muylle L; Wouters E; De Bock R; Peetermans ME
Transfus Med; 1992 Dec; 2(4):289-93. PubMed ID: 1339583
[TBL] [Abstract][Full Text] [Related]
14. Febrile nonhemolytic transfusion reactions to platelets.
Heddle NM
Curr Opin Hematol; 1995 Nov; 2(6):478-83. PubMed ID: 9372039
[TBL] [Abstract][Full Text] [Related]
15. Trend towards reduction of transfusion reactions using prestorage leukocyte-reduced and pooled whole blood-derived platelets and cost savings compared with poststorage whole blood-derived random platelets as evidenced by real-time hemovigilance.
Park N; Correa Medina M; Martinez F; Throssel M; Dasgupta A; Knopfelmacher A; Villamin C; Rivas S; Tomczak N; Garg S; Layton L; Klein K
Lab Med; 2024 May; 55(3):251-254. PubMed ID: 38175635
[TBL] [Abstract][Full Text] [Related]
16. Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol).
Azuma H; Hirayama J; Akino M; Miura R; Kiyama Y; Imai K; Kasai M; Koizumi K; Kakinoki Y; Makiguchi Y; Kubo K; Atsuta Y; Fujihara M; Homma C; Yamamoto S; Kato T; Ikeda H
Transfusion; 2009 Feb; 49(2):214-8. PubMed ID: 18798806
[TBL] [Abstract][Full Text] [Related]
17. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC.
Yazer MH; Podlosky L; Clarke G; Nahirniak SM
Transfusion; 2004 Jan; 44(1):10-5. PubMed ID: 14692961
[TBL] [Abstract][Full Text] [Related]
18. Benefit of prestorage leukocyte depletion of single-donor platelet concentrates.
Chalandon Y; Mermillod B; Beris P; Doucet A; Chapuis B; Roux-Lombard P; Dayer JM
Vox Sang; 1999; 76(1):27-37. PubMed ID: 9933851
[TBL] [Abstract][Full Text] [Related]
19. Platelets expressing P-selectin and platelet-derived microparticles in stored platelet concentrates bind to PSGL-1 on filtrated leukocytes.
Nomura S; Okamae F; Abe M; Hosokawa M; Yamaoka M; Ohtani T; Onishi S; Matsuzaki T; Teraoka A; Ishida T; Fukuhara S
Clin Appl Thromb Hemost; 2000 Oct; 6(4):213-21. PubMed ID: 11030527
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study.
Novotny VM; van Doorn R; Witvliet MD; Claas FH; Brand A
Blood; 1995 Apr; 85(7):1736-41. PubMed ID: 7703481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
